HALO
Halozyme Therapeutics, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders -7.1% ·
aandelenstroom -14.4% ·
netto nieuwe posities -7.7%
— formule
Brede distributie — dalende aandelen en minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 132 | -2 | 91.18M | $6.60B | +5 | −6 |
| Q1 2026 | 136 | +1 | 88.77M | $5.36B | +7 | −7 |
| Q4 2025 | 135 | -1 | 97.38M | $6.16B | +1 | −1 |
| Q3 2025 | 22 | +1 | 49.86M | $3.66B | +1 | −1 |
| Q2 2025 | 19 | 0 | 43.24M | $2.25B | — | — |
| Q1 2025 | 16 | -1 | 15.61M | $996.39M | — | −1 |
| Q4 2024 | 17 | +3 | 17.59M | $840.95M | +4 | −1 |
| Q3 2024 | 13 | -1 | 6.97M | $398.81M | — | −1 |
| Q2 2024 | 14 | — | 8.14M | $426.06M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passief) | 3.06M | +1.0% | $175.19M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passief) | 3.06M | +1.0% | $175.19M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 1.27M | -2.4% | $72.73M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 1.27M | -2.4% | $72.73M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | Norges Bank ✦ (passief) | 1.09M | -10.3% | $62.41M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | Arrowstreet Capital ✦ | 411.41K | +300.4% | $23.55M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Fisher Asset Management ✦ | 324.00K | +6.8% | $18.55M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | D. E. Shaw & Co. ✦ | 306.61K | -36.0% | $17.55M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | Renaissance Technologies ✦ | 255.28K | -32.4% | $14.61M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | Wellington Management ✦ | 65.16K | -83.6% | $3.73M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | Wellington Management ✦ | 65.16K | -83.6% | $3.73M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | Wellington Management ✦ | 65.16K | -83.6% | $3.73M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | Wellington Management ✦ | 65.16K | -83.6% | $3.73M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 52.52K | +9.9% | $3.01M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 52.52K | +9.9% | $3.01M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 52.52K | +9.9% | $3.01M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | Two Sigma Investments ✦ | 49.11K | +0.3% | $2.81M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | Gotham Asset Management ✦ | 43.26K | +52.5% | $2.48M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | Millennium Management ✦ | 26.92K | -93.6% | $1.54M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | Millennium Management ✦ | 26.92K | -93.6% | $1.54M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 21 | Bridgewater Associates ✦ | 11.52K | -65.3% | $659,119 | 0.0% | ▼ Trim | 2 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Citadel Advisors | $18.21M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 8 houders, 32.79M aandelen, $43.93M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer, Director · 9.60K aand · $1.03M
Officer, Director · 3.20K aand · $344,848
Officer, Director · 7.20K aand · $765,778
Officer, Director · 5.70K aand · $587,882
Officer, Director · 9.40K aand · $985,816
Officer, Director · 4.90K aand · $509,827
Officer, Director · 900 aand · $89,062
Officer, Director · 500 aand · $50,228
Officer, Director · 2.10K aand · $213,709
Officer, Director · 9.00K aand · $922,977
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie